Cannovum Cannabis Shareholders’ Equity Growth & History (27N0)
Cannovum Cannabis's shareholders’ equity was €620,000 for fiscal 2024.
View full Cannovum Cannabis company overviewCannovum Cannabis annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | €620,000 | €480,000 | +342.86% |
| 2023 | 2023-12-31 | €140,000 | −€2.3M | −94.14% |
| 2022 | 2022-12-31 | €2.4M | −€9.2M | −79.33% |
| 2021 | 2021-12-31 | €11.6M | €890,000 | +8.34% |
| 2020 | 2020-12-31 | €10.7M | €10.2M | +2271.11% |
| 2019 | 2019-12-31 | €450,000 | €440,000 | +4400.00% |
| 2018 | 2018-12-31 | €10,000 | — | — |
Cannovum Cannabis quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | €623,731 | — | — |
Cannovum Cannabis shareholders’ equity trends
Over the last five fiscal years, Cannovum Cannabis's shareholders’ equity increased from €450,000 to €620,000, a change of €170,000. The latest reported quarter, Q4 2024, shows €623,731.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cannovum Cannabis source filings ↗